-+ 0.00%
-+ 0.00%
-+ 0.00%

J&J: NO GRADE 3 OR HIGHER TREATMENT-RELATED ADVERSE EVENTS REPORTED IN PHASE 1 ANALYSIS

Reuters·11/09/2026 13:56:54

Please log in to view news